Want to join the conversation?
$GILD 2Q15 Call: Non-GAAP R&D expenses were $702MM, up 30% YoverY due to continued progression and expansion of clinical studies, particularly Phase 3 studies in liver disease and oncology areas. Non-GAAP SG&A expenses were up 34% YoverY to $761MM. Ended 2Q15 with $14.7Bil in cash and investments, and generated cash flow from operations of $5.7Bil.
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.
Trivago N.V. (TRVG) announced today that it will release its financial results for the first quarter for the period ended March 31, 2017 on Monday, May 15, 2017. On the same day, trivago N.V.`s management will conduct a webcast beginning at 2:00 PM CET / 8:00 AM Eastern Time. These items will be available in the Investor Relations section of the company`s website at http://ir.trivago.com.